Evidence map›Paper›PMID 34024906›Full record

ArticleMolecular psychiatry2021

White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis.

Maria A Di Biase, Suheyla Cetin-Karayumak, Amanda E Lyall, Andrew Zalesky, Kang Ik Kevin Cho, Fan Zhang, Marek Kubicki, Yogesh Rathi, Monica G Lyons, Sylvain Bouix and 20 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Repurposing medications to prevent psychosis.Npj mental health research · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 10 institutions in 3 countries.

Maria A Di BiaseDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. dibiasem@unimelb.edu.au.ORCID http://orcid.org/0000-0002-7100-651X
Suheyla Cetin-KarayumakDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-3315-5821
Amanda E LyallDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8049-516X
Andrew ZaleskyMelbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Carlton South, VIC, Australia.
Kang Ik Kevin ChoDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Fan ZhangDepartment of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5032-6039
Marek KubickiDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-3989-8212
Yogesh RathiDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Monica G LyonsDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Sylvain BouixDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1326-6054
Tashrif BillahDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Alan AnticevicDepartment of Psychiatry and Psychology, Yale University, New Haven, CT, USA.
Charlie SchleiferUCLA School of Medicine, Los Angeles, CA, USA.
Brendan D AdkinsonYale Interdepartmental Neuroscience Program, Yale School of Medicine, New Haven, CT, USA.
Jie Lisa JiDepartment of Psychiatry and Psychology, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-6280-9070
Zailyn TamayoDepartment of Psychiatry and Psychology, Yale University, New Haven, CT, USA.
Jean AddingtonHotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.ORCID http://orcid.org/0000-0002-8298-0756
Carrie E BeardenDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior and Department of Psychology, University of California-Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-8516-923X
Barbara A CornblattDepartment of Psychiatry and Psychology, The Feinstein Institute for Medical Research, Manhasset, NY, USA.
Matcheri S KeshavanHarvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA, USA.
Daniel H MathalonUniversity of California, San Francisco, San Francisco, CA, USA.
Thomas H McGlashanDepartment of Psychiatry and Psychology, Yale University, New Haven, CT, USA.
Diana O PerkinsDepartment of Psychology, Hofstra North Shore-LIJ School of Medicine, Hempstead, NY, USA.
Kristen S CadenheadDepartment of Psychiatry, University of California San Diego (UCSD), La Jolla, CA, USA.
Ming T TsuangDepartment of Psychiatry, University of California San Diego (UCSD), La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-0076-5340
Scott W WoodsDepartment of Psychiatry and Psychology, Yale University, New Haven, CT, USA.
William S StoneHarvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA, USA.
Martha E ShentonDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Tyrone D CannonDepartment of Psychiatry and Psychology, Yale University, New Haven, CT, USA.
Ofer PasternakDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7078-6446
Brigham and Women's Hospital · USYale University · USBeth Israel Deaconess Medical Center · USUniversity of California, Los Angeles · USUniversity of California San Diego · USFeinstein Institute for Medical Research · USSan Francisco VA Medical Center · USThe University of Melbourne · AUUniversity of Calgary · CAUniversity of North Carolina at Chapel Hill · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Training and DisseminationP41EB015902 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI KIKINIS, RON, WESTIN, CARL-FREDRIK · 2012 to 2022
$20.9M
Medical Scientist Training ProgramT32GM136651 · NIGMS · YALE UNIVERSITY · PI BARBARA I KAZMIERCZAK · 2020 to 2026
$16.5M
1/9 Predictors and Mechanisms of Conversion to PsychosisU01MH081902 · NIMH · YALE UNIVERSITY · PI CANNON, TYRONE D · 2008 to 2018
$12.4M
Novel DT-MRI Analyses of White Matter in SchizophreniaR01MH074794 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI WESTIN, CARL-FREDRIK · 2007 to 2021
$9.6M
5/9 Predictors and Mechanisms of Conversion to PsychosisU01MH082004 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PERKINS, DIANA O. · 2008 to 2018
$7.5M
Administrative Supplement Harmonization of At Risk Multisite Observational Networks for Youth(HARMONY)U01MH081928 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI STONE, WILLIAM SETH · 2008 to 2018
$7.1M
4/9-Predictors and Mechanisms of Conversion to PsychosisU01MH081857 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI CORNBLATT, BARBARA A. · 2008 to 2018
$6.2M
8/9 Predictors and Mechanisms of Conversion to PsychosisU01MH082022 · NIMH · YALE UNIVERSITY · PI WOODS, SCOTT W · 2008 to 2018
$6.0M
Human Connectome Project for Early PsychosisU01MH109977 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI BREIER, ALAN, SHENTON, MARTHA E. · 2016 to 2020
$5.5M
6/9-Predictors and Mechanisms of Conversion to PsychosisU01MH081944 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CADENHEAD, KRISTIN S. · 2008 to 2018
$4.9M
"7/9" Predictors and Mechanisms of Conversion to PsychosisU01MH081984 · NIMH · UNIVERSITY OF CALGARY · PI ADDINGTON, JEAN M · 2008 to 2018
$4.2M
NCATS NIH HHS UL1 TR001863NIBIB NIH HHS P41 EB015902NIGMS NIH HHS T32 GM136651NIMH NIH HHS K01 MH115247NIMH NIH HHS R01 MH074794NIMH NIH HHS R01 MH102377NIMH NIH HHS R01 MH108574NIMH NIH HHS U01 MH076989NIMH NIH HHS U01 MH081857NIMH NIH HHS U01 MH081902NIMH NIH HHS U01 MH081928NIMH NIH HHS U01 MH081944NIMH NIH HHS U01 MH081984NIMH NIH HHS U01 MH082004NIMH NIH HHS U01 MH082022NIMH NIH HHS U01 MH109977
6 · The paper itself

Abstract

Subtle alterations in white matter microstructure are observed in youth at clinical high risk (CHR) for psychosis. However, the timing of these changes and their relationships to the emergence of psychosis remain unclear. Here, we track the evolution of white matter abnormalities in a large, longitudinal cohort of CHR individuals comprising the North American Prodrome Longitudinal Study (NAPLS-3). Multi-shell diffusion magnetic resonance imaging data were collected across multiple timepoints (1-5 over 1 year) in 286 subjects (aged 12-32 years): 25 CHR individuals who transitioned to psychosis (CHR-P; 61 scans), 205 CHR subjects with unknown transition outcome after the 1-year follow-up period (CHR-U; 596 scans), and 56 healthy controls (195 scans). Linear mixed effects models were fitted to infer the impact of age and illness-onset on variation in the fractional anisotropy of cellular tissue (FA

Indexed as

Psychotic DisordersWhite MatterAdolescentAdultChildChild, PreschoolCorpus CallosumHumansLongitudinal StudiesProdromal SymptomsYoung Adult

Identifiers

PMID34024906
PMCPMC8611104
OpenAlexW3164541516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.